an increased cardiovascular risk in patients taking Vioxx compared to those taking a pain medication called naproxen. The Food and Drug Administration then asked Merck to add a warning to the drugs label. But Merck said that the company had conducted its...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Public Database Is Urged to Monitor Drug Safety
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account